Possible side effects of Semaglutide GLP-1 injections include nausea, vomiting, and diarrhea
Variants in the GLP1R gene (such as rs6923761) and the FTO gene (rs9939609) affect appetite signaling and metabolic rate, meaning two patients injecting identical doses may experience different weight loss trajectories
The lack of solid clinical evidence on long-term safety, especially for ongoing use, creates uncertainty about potential interactions
Recent studies have shown that some ED meds can also help with premature ejaculation.15 However, both SSRIs and PDE-5 inhibitors have certain side effect risks that make non-prescription treatment a better place to start
Results vary, and outcomes depend on individual factors including adherence to protocol
Conclusions To summarize, more than 19 years after exenatide's approval, newer once-weekly GLP-1 medicines like semaglutide and tirzepatide have shown long-term efficacy and safety for type 2 diabetes and obesity